BBK Capital Partners »

Cme shares owned by BBK Capital Partners

Quarter-by-quarter ownership of Cme (CME) shares owned by BBK Capital Partners from 13F filings

Historical chart of BBK Capital Partners investment in Cme

Tip: Access up to 7 years of quarterly data

All positions including Cme held by BBK Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cme by BBK Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $597k 2.7k 220.66
2024-06-30 $572k 2.9k 196.63
2024-03-31 $547k 2.5k 215.27

More positions owned by BBK Capital Partners

Procter & Gamble Company (PG)
Apple (AAPL)
Etf Opportunities Trust Formidable Fortr (KONG)
Etf Opportunities Trust Formidable Etf (FORH)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Chemed Corp Com Stk (CHE)
Eaton Vance Tax-Managed Global Dive Eq (EXG)
Flux Pwr Hldgs Com New (FLUX)
Eli Lilly & Co. (LLY)
Gamco Global Gold Nat Res & Com Sh Ben Int (GGN)
Exxon Mobil Corporation (XOM)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)

View all positions for BBK Capital Partners

Top funds holding Cme

Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital World Investors
Jpmorgan Chase & Co
Geode Capital Management
Bank of New York Mellon
Morgan Stanley
T. Rowe Price Associates
Invesco
Northern Trust
Amundi
Vontobel Holding
Guardcap Asset Management

View all funds holding Cme